Effects of the ETA/ETB receptor antagonist, bosentan on endothelin‐1‐induced myocardial ischaemia and oedema in the rat

Abstract

The purposes of this study were to assess the role of ETB receptors in mediating endothelin‐1 (ET‐1)‐induced myocardial ischaemia and oedema in rats and to study the inhibitory action of the novel non‐pep tide ETA/ETB receptor antagonist, bosentan on these actions of ET‐1 Intravenous bolus injection of ET‐1 (1 nmol kg−1) into anaesthetized rats produced marked ST segment elevation of the electrocardiogram without causing arrhythmias. ST segment elevation developed within 30–50 s and persisted for at least 30 min following injection of the peptide Pretreatment of the animals with bosentan (10 mg kg−1, i.v.) inhibited on average by 96% the ST segment elevation elicited by ET‐1 (1 nmol kg−1) compared to the 82% inhibition observed with the ETA receptor‐selective antagonist, FR 139317 (2.5 mg kg−1, i.v.) Bolus injection of ET‐1 (1 nmol kg−1, i.v.) to conscious chronically catheterized rats evoked a transient depressor response followed by a prolonged pressor effect. Corresponding to changes in blood pressure, a transient tachycardia and a sustained bradycardia were observed. ET‐1 (1 nmol kg−1) enhanced albumin extravasation by 119 and 93% in the left ventricle and right atrium, respectively, as measured by the local extravascular accumulation of Evans blue dye Pretreatment of the animals with bosentan (10 mg kg−1) inhibited by 71 and 90% the depressor and pressor actions of ET‐1 (1 nmol kg−1) and the accompanying tachycardia and bradycardia, respectively. FR 139317 (2.5 mg kg−1) attenuated the pressor response to ET‐1 and accompanying bradycardia by 75%, without affecting the depressor action and accompanying tachycardia. ET‐1‐induced albumin extravasation was completely inhibited by bosentan (10 mg kg−1) both in the left ventricle and right atrium, compared to the 86% inhibition observed with FR 139317 (2.5 mg kg−1) Like ET‐1, the ETB receptor‐selective agonist, IRL 1620 (0.3 and 1 nmol kg−1, i.v.) also produced dose‐dependent ST segment elevation in anaesthetized rats and enhanced albumin extravasation (up to 141% of control) in the left ventricle and right atrium, respectively, in conscious rats. These effects of IRL 1620 were completely prevented by bosentan (10 mg kg−1) These results indicate that ETB receptors, albeit to a lesser extent than ETA receptors, are also involved in mediating ET‐1‐induced myocardial ischaemia and oedema in the rat, and suggest the therapeutic potential for bosentan in the treatment of ischaemic myocardial diseases. 1995 British Pharmacological Society